Clinical Trials Directory

Trials / Completed

CompletedNCT04871256

Effects of Septorhinoplasty on Allergic Rhinitis

Effects of Septorhinoplasty on Allergic Rhinitis Evolution

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Mario Pérez Sayáns · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Allergic rhinitis (AR) is a chronic inflammatory disease that affects almost 30% of adult population. Some patients associate septal deviation, main cause of chronic nasal obstruction, and AR. Current literature about AR treatment with septoplasty (STP) is still contradictory, because is thought that patients with AR are not able to appreciate improvement after surgery. Patients diagnosed with allergic rinitis and septal deviation were evaluated to determined life quality and airflow obstruction evolution after STP.

Detailed description

This is a prospective quasi experimental study. After being informed about the study, patients that signed written informed consent were included in the study. In week 0 before surgery, all measurements and questionnaires were performed. 1 month after surgery, measurements were repeated. After screening, patient´s obstruction was evaluated by anterior rhinomanometry (RNMa), and quality of life scored through ESPRINT scale. ESPRINT is a validated Spanish questionnaire about daily life activity, sleep, psycology and perception of affection by allergic rhinitis. Symtoms were evaluated with visual analogue scale (VAS) and clinical history. Symptoms like sneezing, itchy nose, ocular symptoms and/or nasal obstruction. Also medication (intranasal corticosteroid, antileucotrienos, antihistamines eye drops , antishistamines) frequency use was registered.

Conditions

Interventions

TypeNameDescription
PROCEDURESeptorhinoplastyThis intervention will be performed by the same surgeon, after signing of patient inform consent.

Timeline

Start date
2021-01-01
Primary completion
2021-03-01
Completion
2021-03-01
First posted
2021-05-04
Last updated
2021-05-04

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04871256. Inclusion in this directory is not an endorsement.